About Alzheimer's Research Corporation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
Epix Pharmaceuticals, Inc.
2
Cerecin
1
Hoffmann-La Roche
1
Mediti Pharma Inc.
1
National Institute on Aging (NIA)
1
Neurim Pharmaceuticals Ltd.
1
Novartis
1
Pfizer
1
Clinical Trials at Alzheimer's Research Corporation
During the past decade, Alzheimer's Research Corporation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
2007-12-01
2012-06-01
Completed
1,331
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
2007-12-01
2012-04-01
Completed
1,121
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
2008-04-01
Terminated
420
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
2008-05-01
Terminated
236
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
2009-07-01
2012-09-01
Terminated
896
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
2009-07-01
2012-06-01
Completed
716
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alzheimer's Research Corporation" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials, followed by "Epix Pharmaceuticals, Inc." with 2 trials
sponsored, "Cerecin" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Mediti Pharma Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alzheimer's Research Corporation"
#1 collaborator was "Pfizer" with 3 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Neuro-Hitech" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Alzheimer's Research Corporation
According to Clinical.Site data, the most researched conditions in "Alzheimer's Research Corporation" are
"Alzheimer's Disease" (9 trials), "Alzheimer Disease" (2 trials), "Aggression" (1 trials), "Agitation" (1 trials) and "Alzheimer Dementia" (1 trials). Many other conditions were trialed in "Alzheimer's Research Corporation" in a lesser frequency.
Clinical Trials Intervention Types at Alzheimer's Research Corporation
Most popular intervention types in "Alzheimer's Research Corporation" are "Drug" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "PRX-03140" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Alzheimer's Research Corporation
The vast majority of trials in "Alzheimer's Research Corporation" are
12 trials for "All" genders.
Clinical Trials Status at Alzheimer's Research Corporation
Currently, there are NaN active trials in "Alzheimer's Research Corporation".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Alzheimer's Research Corporation,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Alzheimer's Research Corporation, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".